BiotechTube
NP Medical

NP Medical

Clinton, United States· Est.
npmedical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

NP Medical is a long-established, private medical device manufacturer with a core focus on vascular access site management and critical IV components. The company leverages over 35 years of experience and a strong IP portfolio (140+ patents) to provide products that promote infection prevention, workflow efficiency, and patient safety. It is certified to ISO 13485:2016 and FDA QSR, supplying over 6 billion valves to date. NP Medical is now driving innovation towards data-enabled devices and home-based therapies, aiming to transition care to lower-acuity settings.

Medical DevicesDrug Delivery

Technology Platform

Mechanical and emerging data-enabled fluid management platform for vascular access, centered on proprietary needle-free connector technology (e.g., Self-Opening Split Septum design) and IV components.

Opportunities

The shift of healthcare delivery to lower-acuity and home settings presents a major growth opportunity for NP Medical's next-generation, data-enabled devices designed for simplified, monitored therapy.
Additionally, the persistent need to reduce hospital-acquired infections and total cost of care drives continuous demand for its core safety-focused vascular access products.

Risk Factors

The company faces intense competition from larger, well-capitalized medtech firms in the vascular access space.
Its strategic evolution into data-enabled devices introduces new regulatory (software, cybersecurity) and execution risks.
As part of a larger corporation (Jabil), shifts in corporate strategy could impact resource allocation and focus.

Competitive Landscape

NP Medical competes in the vascular access device market against major global players like Becton Dickinson, ICU Medical, and B. Braun, which offer broad portfolios and extensive distribution. Its differentiation lies in deep specialization in fluid management, a strong IP portfolio (140+ patents), and a focus on cost-effective, safety-driven design for both critical care and value market segments.

More companies in Drug Delivery & Formulation →More companies in United States →